{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:24:06Z","timestamp":1791829446480,"version":"4.3.4"},"reference-count":33,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polish Cardiac Society in cooperation with Servier","award":["80\/2021"],"award-info":[{"award-number":["80\/2021"]}]},{"name":"Polish Cardiac Society in cooperation with Servier","award":["2023\/ABM\/02\/00011"],"award-info":[{"award-number":["2023\/ABM\/02\/00011"]}]},{"name":"Polish Medical Research Agency","award":["80\/2021"],"award-info":[{"award-number":["80\/2021"]}]},{"name":"Polish Medical Research Agency","award":["2023\/ABM\/02\/00011"],"award-info":[{"award-number":["2023\/ABM\/02\/00011"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background: Many risk factors for cancer therapy-related cardiovascular toxicity overlap with risk factors for atherosclerosis. According to the ESC 2022 Cardio-Oncology Guidelines, coronary computed tomography angiography and coronary artery calcium score are not recommended as part of routine risk assessment prior to oncological treatment. The aim of this study was to prospectively assess the influence of coronary artery calcium score (CAC score) on cancer therapy-related cardiac dysfunction in patients with moderate and high risk of cardiovascular toxicity, qualified for anthracycline treatment. Methods: In all patients, risk factors were collected, laboratory tests, echocardiography with global longitudinal strain (GLS) assessment and coronary artery tomography with coronary artery calcium score were performed. A total of 80 patients were included in the study, of which 77 (96.25%) were followed for an average of 11.5 months. The mean age at baseline was 60.5 years and 72 (93.51%) were women. Results: During observation, five patients (6.49%) died, including two due to heart failure and three due to cancer progression. The majority of patients (59, 76.6%) had breast cancer, 11 (14.3%) were diagnosed with sarcoma and seven (9.1%) with lymphoma. According to the HFA-ICOS risk score, 40 patients (51.9%) were classified as moderate risk (MR), and 37 patients (48.1%) as high risk (HR) for cancer therapy-related cardiovascular toxicity. A CAC score greater than 100 was calculated in 17 (22.1%) patients and greater than 400 in three (3.9%) patients. The CAC score above zero was more common in older patients and in patients classified as high risk (p &lt; 0.001). There was also a significant association between CAC score and hypertension, hyperlipidemia, chronic kidney disease, and the level of NT-proBNP. During 12-month follow-up, mild CTRCD occurred in 38 (49.4%) patients, moderate CTRCD was diagnosed in seven (9.1%), and severe in three (3.9%) patients. In the univariable analysis, CTRCD was more common in the high-risk group (p = 0.005) and in patients with a CAC score greater than zero (p = 0.036). In multivariable analysis, the incidence of CTRCD remains higher in the CAC score &gt; 0 group, even after adjusting for age, hypertension, and hyperlipidemia. In this study group, the CTRCD rates increased with the HFA-ICOS risk score. Conclusions: In moderate and high-risk patients, a coronary artery calcium score greater than zero was identified as a significant risk factor for the development of cancer therapy-related cardiac dysfunction during anthracycline-based treatment. Furthermore, the HFA-ICOS risk score demonstrated good correlation with the incidence of CTRCD in this study, supporting its validity as a predictive tool in patients receiving anthracycline therapy.<\/jats:p>","DOI":"10.3390\/ph18081102","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T08:13:31Z","timestamp":1753431211000},"page":"1102","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Coronary Artery Calcium Score as a Predictor of Anthracycline-Induced Cardiotoxicity: The ANTEC Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4865-652X","authenticated-orcid":false,"given":"Anna","family":"Borowiec","sequence":"first","affiliation":[{"name":"Non-Commercial Clinical Research Outpatient Clinic, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Ozdowska","sequence":"additional","affiliation":[{"name":"Department of Cancer & Cardio-Oncology Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Rosinska","sequence":"additional","affiliation":[{"name":"Digital Medicine Center, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka Maria","family":"Zebrowska","sequence":"additional","affiliation":[{"name":"Unit for Screening Studies in Inherited Cardiovascular Diseases, The Cardinal Stefan Wyszynski National Institute of Cardiology, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Jasek","sequence":"additional","affiliation":[{"name":"Department of Cancer & Cardio-Oncology Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Kotowicz","sequence":"additional","affiliation":[{"name":"Cancer Biomarker and Cytokines Laboratory Unit, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Waniewska","sequence":"additional","affiliation":[{"name":"Department of Radiology I, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Kosela-Paterczyk","sequence":"additional","affiliation":[{"name":"Department of Soft Tissue\/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Lampka","sequence":"additional","affiliation":[{"name":"Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pogoda","sequence":"additional","affiliation":[{"name":"Department of Brest Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Nowecki","sequence":"additional","affiliation":[{"name":"Department of Brest Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Walewski","sequence":"additional","affiliation":[{"name":"Department of Lymphoid Malignancies, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.5551\/jat.RV17027","article-title":"Mechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis","volume":"25","author":"Mukai","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/eurjpc\/zwac185","article-title":"Incidental coronary calcium in cancer patients treated with anthracycline and\/or trastuzumab","volume":"29","author":"Hooks","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_4","first-page":"1","article-title":"Use of computed tomography coronary calcium score for prediction of cardiovascular events in cancer patients: A retrospective cohort analysis","volume":"10","author":"Patel","year":"2024","journal-title":"Cardiooncology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jacc.2023.06.040","article-title":"Association of Coronary Artery Calcium Detected by Routine Ungated CT Imaging With Cardiovascular Outcomes","volume":"82","author":"Peng","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1093\/ehjci\/jeab292","article-title":"Clinical applications of cardiac computed tomography: A consensus paper of the European Association of Cardiovascular Imaging-part II","volume":"23","author":"Pontone","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2011.05.025","article-title":"Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy","volume":"58","author":"Acar","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","first-page":"153","article-title":"Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy","volume":"35","author":"Michalowska","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","article-title":"Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: An observational clinical cohort study","volume":"60","author":"Seicean","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","first-page":"302","article-title":"Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function","volume":"31","author":"Chotenimitkhun","year":"2015","journal-title":"Can. J. Cardiol."},{"key":"ref_11","first-page":"1395","article-title":"Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and\/or trastuzumab: A systematic review and meta-analysis","volume":"32","author":"Obasi","year":"2021","journal-title":"Cancer Causes Control"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kim, J., Nishimura, Y., Kewcharoen, J., and Yess, J. (2021). Statin Use Can Attenuate the Decline in Left Ventricular Ejection Fraction and the Incidence of Cardiomyopathy in Cardiotoxic Chemotherapy Recipients: A Systematic Review and Meta-Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10163731"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e937","DOI":"10.1016\/j.clml.2020.07.003","article-title":"Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study","volume":"20","author":"Afzal","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1074248418821721","article-title":"Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial","volume":"24","author":"Nabati","year":"2019","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjcard.2021.07.001","article-title":"Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy","volume":"156","author":"Shahid","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamacardio.2016.4320","article-title":"Statins and the Prevention of Heart Disease","volume":"2","author":"Ziaeian","year":"2017","journal-title":"JAMA Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.2023.11887","article-title":"Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial","volume":"330","author":"Neilan","year":"2023","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"EVIDoa2200097","DOI":"10.1056\/EVIDoa2200097","article-title":"Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment","volume":"1","author":"Hundley","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ehjcvp\/pvad031","article-title":"Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines","volume":"9","author":"Thavendiranathan","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_20","first-page":"7","article-title":"A comparative assessment of coronary artery calcification on chest CT scans of patients referred to a cardio-oncology clinic","volume":"2","author":"Brann","year":"2016","journal-title":"Cardiooncology"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gernaat, S.A., I\u0161gum, I., De Vos, B.D., Takx, R.A., Young-Afat, D.A., Rijnberg, N., Grobbee, D.E., van der Graaf, Y., De Jong, P.A., and Leiner, T. (2016). Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167925"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e014829","DOI":"10.1161\/CIRCIMAGING.122.014829","article-title":"Cardiovascular Risk Stratification by Automatic Coronary Artery Calcium Scoring on Pretreatment Chest Computed Tomography in Diffuse Large B-Cell Lymphoma Receiving Anthracycline-Based Chemotherapy: A Multicenter Study","volume":"16","author":"Shen","year":"2023","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.breast.2022.07.003","article-title":"Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy","volume":"65","author":"Kim","year":"2022","journal-title":"Breast"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Koutroumpakis, E., Xu, T., Lopez-Mattei, J., Pan, T., Lu, Y., Irizarry-Caro, J.A., Mohan, R., Zhang, X., Meng, Q.H., and Lin, R. (2022). Coronary artery calcium score on standard of care oncologic CT scans for the prediction of adverse cardiovascular events in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.1071701"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/14017431.2015.1039572","article-title":"Coronary artery calcification detected in lung cancer screening predicts cardiovascular death","volume":"49","author":"Rasmussen","year":"2015","journal-title":"Scand. Cardiovasc. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100119","DOI":"10.1016\/j.ajpc.2020.100119","article-title":"Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium","volume":"4","author":"Wang","year":"2020","journal-title":"Am. J. Prev. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-021-06192-w","article-title":"Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer","volume":"188","author":"Battisti","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Suntheralingam, S., Fan, C.-P.S., Calvillo-Arg\u00fcelles, O., Abdel-Qadir, H., Amir, E., and Thavendiranathan, P. (2022). Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030847"},{"key":"ref_29","first-page":"273","article-title":"Anthracycline-induced cardiovascular toxicity: Validation of the Heart Failure Association and International Cardio-Oncology Society risk score","volume":"46","author":"Zamora","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"ehae666.3188","DOI":"10.1093\/eurheartj\/ehae666.3188","article-title":"Validation of the HFA-ICOS risk assessment tool with real-world data from a prospective cohort of breast cancer patients in treatment with anthracyclines and trastuzumab","volume":"45","author":"Guerra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Borowiec, A., Ozdowska, P., Rosinska, M., Jagiello-Gruszfeld, A., Jasek, S., Waniewska, J., Kotowicz, B., Kosela-Paterczyk, H., Lampka, E., and Makowka, A. (2023). Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0288146"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jcct.2022.05.006","article-title":"Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with The American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance","volume":"16","author":"Edvardsen","year":"2022","journal-title":"J. Cardiovasc. Comput. Tomogr."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/8\/1102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:15:44Z","timestamp":1760033744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/18\/8\/1102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ph18081102"],"URL":"https:\/\/doi.org\/10.3390\/ph18081102","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}